SAN DIEGO, March 6, 2012 /PRNewswire/ -- CareFusion
today announced an agreement to acquire PHACTS, LLC, a
Seattle-based technology and consulting company that
helps hospital pharmacies better manage inventory, reduce
pharmaceutical costs and streamline operations. Terms of
the deal were not disclosed.
The acquisition will advance CareFusion's strategy to
offer hospitals
safe and efficient systems to manage medication
throughout their facilities - from the loading dock to
the patient bedside and through to waste segregation. By
adding
PHACTS to the company's core Pyxis® dispensing
technologies portfolio, CareFusion will be able to
provide health systems better visibility into drug
inventories, helping to reduce on-hand inventory,
streamline staff workflow, manage drug shortages and
improve financial performance.
In November 2010, CareFusion announced a global marketing
relationship as the exclusive reseller of PHACTS pharmacy
inventory management software and automation. Through
this partnership, PHACTS expanded its base of customers
by 50 percent to more than 200 customers.
"With the addition of PHACTS market-leading products
to our portfolio, CareFusion is better positioned to help
hospitals realize significant savings, including a
reduction in medication inventory on-hand levels by up to
40 percent," said Tom Leonard, president of Medical
Systems at CareFusion. "The acquisition will enable
us to more directly integrate PHACTS capabilities into
our core CareFusion
Pyxis technologies and expand our portfolio to
further strengthen our comprehensive, end-to-end
medication management offering."
PHACTS products include both software and automation
solutions for health systems and hospital pharmacies.
With PHACTS software, health systems can track drug
inventories in near real time across all pharmacy
locations, gaining visibility that can help accelerate
inventory turns, maintain stock at optimal levels and
reduce waste from expired drugs - all resulting in lower
medication costs. PHACTS automation helps hospitals
efficiently package and label medications, applying
barcodes that can improve accuracy at the bedside and
helping to increase medication safety.
The PHACTS portfolio includes:
-
Pharmogistics® pharmacy inventory management software
that ties directly into hospital IT systems to track
drugs and helps hospitals increase accuracy, simplify
workflow processes and improve productivity.
Pharmogistics software operates automated carousel
hardware for high-density medication storage and
retrieval in the hospital pharmacy;
-
PharmoPack™ high-speed medication packaging and barcode
labeling system for oral drugs in solid form; and,
-
PharmoCode™ barcode labeling system for non-oral
medications and devices, such as vials and syringes.
Subject to customary conditions, the acquisition is
expected to close in the fourth quarter of CareFusion
fiscal year 2012. The acquisition is expected to be
neutral to adjusted earnings in the first year and
increasingly accretive thereafter.
About PHACTS
PHACTS has more than 35 years of experience in working
with pharmacies specializing in pharmaceutical
distribution, inventory management, reducing waste and
expired medications, pharmacy automation, logistics,
workflow process, and barcode medication administration.
The company pioneered software to operate pharmacy
carousels and manage pharmacy inventory in hospitals.
About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving
the health care industry with products and services that
help hospitals measurably improve the safety and quality
of care. The company develops market-leading technologies
including Alaris® infusion pumps, Pyxis® automated
dispensing and patient identification systems, AVEA®,
AirLife™ and LTV® series ventilation and respiratory
products, ChloraPrep® skin prep products, MedMined®
services for data mining surveillance, Nicolet™
neurological monitoring and diagnostic products, V.
Mueller® surgical instruments, and an extensive line of
products that support interventional medicine. CareFusion
employs more than 14,000 people across its global
operations. More information may be found at
www.carefusion.com.
Cautions concerning forward-looking statements
The CareFusion news release and the information contained
herein contains forward-looking statements addressing
expectations, prospects, estimates and other matters that
are dependent upon future events or developments. The
matters discussed in these forward-looking statements are
subject to risks and uncertainties that could cause
actual results to differ materially from those projected,
anticipated or implied. Forward looking statements
include, but are not limited to, statements about the
timing of the anticipated acquisition, the potential
benefits and synergies of the anticipated acquisition,
including the expected impact on future financial and
operating results, and post acquisition plans and
intentions. The forward-looking statements contained
herein are based on the current expectations and
assumptions of CareFusion and not on historical facts.
The following important factors, among others, could
cause actual results to differ materially from those set
forth in the forward-looking statements: the
satisfaction of conditions to closing the agreement; the
risk that the businesses will not be integrated
successfully; and the risk that benefits and synergies
from the acquisition may not be fully realized or may
take longer to realize than expected. Additional factors
that may affect future results are described in
CareFusion's Quarterly Report on Form 10-Q for the
quarter ended December 31, 2011 and Annual Report on Form
10-K for the year ended June 30, 2011. Except to the
limited extent required by applicable law, CareFusion
undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new
information, future events or otherwise.
SOURCE CareFusion
Recommend:
